Brief: IMCD China Acquires Daoqin Biological Technology And Affiliates

IMCD

13/12/2024 06:02

Dec 13 (Reuters) - IMCD NV  IMCD.AS :
    * IMCD CHINA STRENGTHENS ITS LIFE SCIENCE BUSINESS WITH THE
ACQUISITION OF DAOQIN
    * CLOSING OF TRANSACTION EXPECTED TO TAKE PLACE IN Q2 OF
2025.
    * TO ACQUIRE DAOQIN BIOLOGICAL TECHNOLOGY AND AFFILIATES IN
CHINA

Source text:  ID:nGNEWgsR6 
Further company coverage:  IMCD.AS 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))